Suppr超能文献

线粒体基因组在常染色体显性多囊肾病发病机制中的可能作用。

Possible role of the mitochondrial genome in the pathogenesis of autosomal dominant polycystic kidney disease.

机构信息

Michael Stern Laboratory for Polycystic Kidney Disease, Westmead Institute for Medical Research, The University of Sydney, Westmead, New South Wales, Australia.

Department of Renal Medicine, Westmead Hospital, Westmead, New South Wales, Australia.

出版信息

Nephrology (Carlton). 2021 Nov;26(11):920-930. doi: 10.1111/nep.13957. Epub 2021 Aug 9.

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is the most common monogenic renal disease in adults and is due to heterozygous germ line variants in either PKD1, PKD2 or rarely other genes. It is characterized by marked intra-familial disease variability suggesting that other genetic and/or environmental factors are involved in determining the lifetime course ADPKD. Recently, research indicates that polycystin-mediated mitochondrial dysfunction and metabolic re-programming contributes to the progression of ADPKD. Although biochemical abnormalities have gained the most interest, variants in the mitochondrial genome could be one of the mechanisms underlying the phenotypic variability in ADPKD. This narrative review aims to evaluate the role of the mitochondrial genome in the pathogenesis of APDKD.

摘要

常染色体显性遗传性多囊肾病(ADPKD)是成人中最常见的单基因肾脏疾病,是由 PKD1、PKD2 或极少数其他基因中的杂合性种系变异引起的。其特征是家族内疾病变异性显著,提示其他遗传和/或环境因素参与决定 ADPKD 的终生病程。最近的研究表明,多囊蛋白介导的线粒体功能障碍和代谢重编程导致 ADPKD 的进展。尽管生化异常最受关注,但线粒体基因组中的变异可能是 ADPKD 表型变异性的机制之一。本综述旨在评估线粒体基因组在 ADPKD 发病机制中的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验